Dublin, 19 September 2023
Orphan Drug Consulting is thrilled to announce that our very own CEO and Founder, Evelyn Kelly, has been selected as a finalist for the esteemed Founder of the Year Award, hosted by Enterprise Ireland. This prestigious recognition is an integral part of the HPSU Founders Forum, an annual event that brings together visionary leaders and entrepreneurs in the start-up community.
The HPSU Founders Forum, renowned for celebrating exceptional leadership and innovation in the entrepreneurial landscape, plays host to Founder Forum members and distinguished guests who represent the very best of the start-up ecosystem. This unique platform provides a forum for founders to nominate their peers, presenting their remarkable journeys and achievements to a distinguished judging panel. The culminating moment of the event is the announcement of the Founder of the Year, who is chosen for their outstanding contributions to the world of business and their visionary leadership.
Evelyn Kelly, the driving force behind Orphan Drug Consulting, has been nominated by her peers for her unwavering commitment to improving the lives of individuals affected by rare diseases. Under her leadership, Orphan Drug Consulting has grown into a globally recognised consultancy, dedicated to facilitating the development and distribution of life-saving orphan drugs. Evelyn’s tireless efforts in this field have not only impacted the pharmaceutical industry but have also brought hope to countless patients and their families.
“I am deeply honoured to be nominated as a finalist for the Founder of the Year Award,” said Evelyn Kelly, upon learning of her nomination. “This recognition is a testament to the incredible team at Orphan Drug Consulting and the inspiring work we do to make a difference in the lives of those with rare diseases. It’s a true privilege to be part of the HPSU Founders Forum and to contribute to the vibrant start-up ecosystem.”
Orphan Drug Consulting has gained widespread acclaim for its commitment to fostering innovation in rare disease treatments, and Evelyn Kelly’s leadership has been a driving force behind this mission. Her dedication to creating a positive impact in the world of healthcare has earned her this well-deserved nomination.
The entire team at Orphan Drug Consulting congratulates Evelyn Kelly on this remarkable achievement and wishes her the best of luck as a finalist for the Founder of the Year Award. Her nomination is a reflection of her exceptional leadership, dedication, and the transformative work she has spearheaded within the industry.
For media inquiries, please contact:
Margaret Mary Hicks | Senior Marketing Associate
firstname.lastname@example.org | +353 (0)87 960 3697
About Orphan Drug Consulting:
Orphan Drug Consulting is a leading consultancy dedicated to advancing the development and accessibility of orphan drugs. With a mission to improve the lives of individuals affected by rare diseases, the company provides expert guidance to pharmaceutical companies, biotech firms, and organisations working to bring innovative treatments to market. Led by CEO and Founder Evelyn Kelly, Orphan Drug Consulting is at the forefront of driving positive change in the healthcare industry.Leave a reply